TCG Labs Soleil’s Juri Biosciences is offering EpimAb Biotherapeutics up to $210 million biobucks for exclusive licensing ...

Indian CDMOs are strategically expanding through acquisitions in the US and Europe, driven by global pharma's nearshoring ...

Pharma company stocks tumbled after Donald Trump announced a plan to reduce U.S. drug prices, but regained some ground on belief the plan would be hard to implement Drug prices are expected to decline ...

The AI chip maker’s shares rose more than 5% after hours as quarterly revenue surged to a record $44 billion.

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

As geopolitical tensions prompt global pharmaceutical giants to pivot away from China, India's Contract Development and ...

China's Livzon Pharmaceutical Group Inc. will spend VND5.73 trillion ($221 million) to acquire almost 65 per cent of ...

Merck KGaA is filing for global regulatory approvals of pimicotinib after it met primary and secondary endpoints in a Phase ...

- Establishing High-quality Pharmaceutical Logistics Service Systems - ...

While MIC2025 was officially shelved from public discourse in 2018 due to intense international backlash, its core objectives ...

This monthly report outlines key developments in China’s antitrust sector for May. The following events merit special ...

ORI Capital is planning a US$350 million fund to focus on Chinese biotech, with hopes that AI will help beat the market.